Aviso Financial’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.69M Buy
23,786
+589
+3% +$114K 0.17% 69
2025
Q4
$4.26M Buy
23,197
+990
+4% +$174K 0.16% 68
2025
Q3
$3.41M Buy
22,207
+1,093
+5% +$165K 0.14% 83
2025
Q2
$2.95M Buy
21,114
+1,124
+6% +$158K 0.13% 83
2025
Q1
$2.94M Buy
19,990
+981
+5% +$142K 0.14% 81
2024
Q4
$2.49M Buy
19,009
+131
+0.7% +$18.3K 0.13% 85
2024
Q3
$2.94M Buy
18,878
+1,412
+8% +$228K 0.15% 79
2024
Q2
$2.72M Buy
+17,466
New +$2.63M 0.15% 74

Other funds holding AZN

Aviso Financial's AZN Position: Q1 2026 in Review

Aviso Financial increased its AstraZeneca (AZN) stake by 2.5% in Q1 2026, buying an estimated $114K and bringing the position to 23,786 shares worth $4.69M. The position accounts for 0.17% of the portfolio, ranked #69.

Aviso Financial first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Aviso Financial held 23,786 shares of AstraZeneca worth $4.69M as of Q1 2026.
  • Aviso Financial bought 589 AstraZeneca shares in Q1 2026, an estimated $114K.
  • AstraZeneca made up 0.17% of Aviso Financial's portfolio in Q1 2026, its #69 holding.
  • Aviso Financial first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.